Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | CAPG | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
mRNA | HSPG2 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
mRNA | SMCHD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | LAMB2 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-07 |
mRNA | PTPRM | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
mRNA | RPS6 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | NABP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
mRNA | ARHGAP19-SLIT1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | FBXO5 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |